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Equine viral arteritis (EVA) is a cause of abortion and neonatal
deaths. In France, surveillance of EVA is based mostly on sero-
logical testing of all or part of the breeding horses, depending on
the studbooks’ regulations. Hence, EVA incidence is not precisely
known in the overall breeding population. The ﬁrst objective of
this study was to estimate the number of EVA cases and out-
breaks detected by the equine breeding stock surveillance be-
tween 2006 and 2013 in France, by establishing suitable rules for
identiﬁcation of seroconversion. The second objective was to
assess the surveillance sensitivity, after having estimated the
total number of outbreaks that occurred in breeding stock during
this period using a capture-recapture model. Data from breeding
mares which exhibited at least one positive result in serology
using viral neutralization test between 2006 and 2013 were used
for analysis (n¼1,645). Data consisted of the annual antibody
titers and the location of the mares (towns). Seroconversion was
deﬁned as a change in antibody titer from negative to at least 32
or a three-fold increase. The number of seroconversions was
counted for each town and modeled using an unilist zero-trun-
cated binomial (ZTB) capture-recapture model with R software.
The binomial denominator was the number of horses tested in
each infected town. From 2006 to 2013, 239 cases of serocon-
version located in 177 towns (outbreaks) were identiﬁed. During
this period, the number of outbreaks in breeding stock was
estimated at 1,482 (CI95% 1,257-1,815) using the ZTB model.
Consequently, it is estimated that over 1,000 outbreaks were not
detected and the surveillance sensitivity at the town level was
estimated around 12% (CI95% 10%-14%). This study revealed a
signiﬁcant number of outbreaks in breeding stock. However, the
surveillance sensitivity seems underestimated, especially due to
lack of details related to the holdings, such as the number of at
risk contacts or their precise address (the holdings list was not
available and several holdings may be located within the same
town). Nevertheless, the sensitivity could certainly be improved
by including more breeding horses in the active surveillance.
This study is the ﬁrst in France to estimate the EVA incidence in
breeding stock and to assess quantitatively the surveillance
sensitivity. Moreover, the rules for identiﬁcation of seroconver-
sion deﬁned in this study may be used to analyze other EVA
surveillance datasets based on serology, such as testing before
sales or international trade, and even compulsory or voluntarypassive surveillance. Such rules, adjusted to the local environ-
ment, could conceivably be applied in other countries with EVA
surveillance programs.085
Re-launch of Equinella: a web-based equine disease
reporting and information platform
F. Wohlfender-Remy*1,2, R. Struchen 1, C. Graubner 2,
S. Balmer 3, D. Hadorn 3
1Veterinary Public Health Institute, Vetsuisse Faculty, University
Bern, Switzerland; 2 Institut suisse de medecine equine, Vetsuisse
Faculty, University Bern, Switzerland; 3 Federal Food Safety and
Veterinary Ofﬁce, Bern, Switzerland
Equinella (www.equinella.ch) is a Swiss voluntary veterinary
reporting system for equine infectious diseases ﬁrst established in
1990. It focuses on equine diseases not notiﬁable by Swiss law. In
2012, an evaluation of the old paper-based system showed that it
was not representative anymore(1). Based on the ﬁndings from a
survey, a new electronic reporting system was developed as a
collaboration between the Federal Food Safety and Veterinary
Ofﬁce, stakeholders from research (Vetsuisse Faculty, Bern) and
the Swiss Association of Equine Practitioners. The new Equinella
is based on a user-friendly web-based platform (functional since
November 2013) and allows registered veterinarians to report
symptoms and equine diseases either using computers or
portable devices. Participants beneﬁt from various non-monetary
incentives: access to a table and interactive map of all incoming,
anonymized reports, a monthly newsletter and a mobile phone
text message service to alarm them in case of an outbreak.
Furthermore, they can contact and draw from the expertise of the
Equinella specialists team and attend one free professional
development course per year. Outdoor smartphones were pro-
vided to those interested. To facilitate and standardize data
collection veterinarians can choose clinical symptoms or diseases
from pre-deﬁned checklists. Data on the equid and the holding
are collected (no unique identiﬁers required to preserve ano-
nymity). Additional information can be entered in a free text box
and pictures can be uploaded. A reminder email is automatically
sent to all registered veterinarians (n¼ 77, 31.08.2015) once a
month. Recipients can then either conﬁrm that they had no
clinical observations of relevance to Equinella in their practice in
the previous month or report their observations retrospectively.
The monthly proportion of veterinarians that either submitted a
report or conﬁrmed not having observed any relevant cases var-
ied between 41.6% and 87.2% (median ¼ 71.4%). A total of 262
reports were submitted (November 2013 - August 2015; median
cases per month: 8 (min¼2, max¼48)): 82 (31.3%) included only
symptoms, 40 (15.3%) only diseases and 140 (53.4%) had both.
EHV-1 and Strangles were most frequently diagnosed (clinical
and/or laboratory diagnosis), whereas fever of unknown origin
was the most frequently reported symptom. Equinella currently
covers 50% of the Swiss equine population. Near real-time anal-
ysis of the Equinella data beneﬁt the early detection of new, exotic
and re-emerging equine diseases; thereby allowing appropriate
measures in a timely manner for the protection of the equine
population. Furthermore, experiences with Equinella might help
establishing similar early disease detection systems for other
animal species.
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